|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Department of Pneumology (Drs. Cataldo, Bartsch, and Louis), Laboratory of Biology of Tumors and Development (Drs. Cataldo and Foidart), University of Liège, Liège, Belgium; and Respiratory Cell and Molecular Biology Research Division (Drs. Djukanovic and Lau), University of Southampton, Southhampton, UK.
Correspondence to: Didier Cataldo, MD, Department of Pneumology, CHU Sart-Tilman, 4000 Liège, Belgium; e-mail: Didier.Cataldo{at}ulg.ac.be
Background: Sputum induction by hypertonic saline solution inhalation is widely used to study airways secretions in patients with asthma. However, hypertonic saline solution is a potent indirect bronchoconstrictor.
Study objectives: We studied the validity of isotonic saline solution (0.9%) inhalation as a means to induce sputum by comparing it to hypertonic saline solution (4.5%) inhalation.
Patients: Sixteen patients with moderate-to-severe asthma reporting a clinical history of mucus hypersecretion.
Methods: Subjects underwent sputum induction twice at 1-week intervals. Saline solution (hypertonic or isotonic) was inhaled for three periods of 5 min. The parameters assessed in sputum samples were cell counts, sodium, eosinophil cationic protein (ECP), and albumin concentrations, osmolality, and pro-matrix metalloproteinase (MMP)-9 activity by zymography.
Results: The maximal fall in peak expiratory flow during sputum induction was greater after inhalation of hypertonic saline solution than after inhalation of isotonic saline solution (p < 0.01). Each subject produced analyzable sputum on both visits. There were no statistically significant differences in total and differential sputum cell counts, and the reproducibility coefficients were high for eosinophils and neutrophils when comparing the two methods. Likewise, sputum levels of ECP and albumin as well as sputum pro-MMP-9 activity were not different between the two methods, and were highly reproducible as shown by high intraclass coefficients (Ri) of correlation (0.72, 0.74, and 0.77 for ECP, albumin, and pro-MMP-9, respectively). Sputum sodium concentrations and osmolality were higher after inhalation of hypertonic saline solution (p < 0.05).
Conclusion: In patients with moderate-to-severe asthma reporting a clinical history of mucus hypersecretion, inducing sputum by isotonic or hypertonic saline solution inhalation leads to comparable results in eosinophil and neutrophil cell counts and fluid phase mediators/proteins.
Key Words: albumin asthma eosinophil cationic protein metalloproteinases osmolality sputum
This article has been cited by other articles:
![]() |
H. van der Vaart, D. S. Postma, W. Timens, H. F. Kauffman, M. N. Hylkema, and N. H.T. ten Hacken Repeated sputum inductions induce a transient neutrophilic and eosinophilic response. Chest, October 1, 2006; 130(4): 1157 - 1164. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kulkarni, N. Pierse, L. Rushton, and J. Grigg Carbon in airway macrophages and lung function in children. N. Engl. J. Med., July 6, 2006; 355(1): 21 - 30. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E. Carpagnano, M P. Foschino Barbaro, M. Cagnazzo, G Di Gioia, T Giliberti, C Di Matteo, and O Resta Use of Exhaled Breath Condensate in the Study of Airway Inflammation After Hypertonic Saline Solution Challenge Chest, November 1, 2005; 128(5): 3159 - 3166. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Edwards, J. C. Man, P. Brand, J. P. Katstra, K. Sommerer, H. A. Stone, E. Nardell, and G. Scheuch Inhaling to mitigate exhaled bioaerosols PNAS, December 14, 2004; 101(50): 17383 - 17388. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Cianchetti, E. Bacci, L. Ruocco, M.L. Bartoli, M. Ricci, T. Pavia, F.L. Dente, A. Di Franco, B. Vagaggini, and P.L. Paggiaro Granulocyte markers in hypertonic and isotonic saline-induced sputum of asthmatic subjects Eur. Respir. J., December 1, 2004; 24(6): 1018 - 1024. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Marc, P. Korosec, M. Kosnik, I. Kern, M. Flezar, S. Suskovic, and J. Sorli Complement Factors C3a, C4a, and C5a in Chronic Obstructive Pulmonary Disease and Asthma Am. J. Respir. Cell Mol. Biol., August 1, 2004; 31(2): 216 - 219. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |